OKYO Pharma (OKYO) CDO JACOB GARY S Buys 3,500 Shares

What Happened JACOB GARY S, Chief Development Officer and a director of OKYO Pharma Ltd (OKYO), acquired 3,500 shares in an open-market purchase on July 21, 2026, at $1.40 per share for a total of $4,900. This transaction is a purchase (often of more interest to investors than a sale) and was reported via an amended Form 4.

Key Details

• Transaction date and price: 2026-07-21 — 3,500 shares @ $1.40 each (total $4,900). Transaction code: P (purchase).
• Filing: Amended Form 4 (Form 4/A) filed Aug 7, 2026 to correct the transaction code; the original Form 4 was filed July 23, 2026. The amendment states no other transactions were affected.
• Shares owned after transaction: Not specified in the information provided here — see the Form 4 for "Amount Beneficially Owned Following Reported Transaction" if available.
• Notable footnotes: Amendment solely corrects the transaction code; no other substantive changes reported.

Context This is a small open-market buy by a company executive (about $4.9k), which some investors view as a modest positive signal but does not, by itself, indicate a change in company outlook. The amended filing is administrative — correcting the transaction code — and does not report any additional trades. Check the full Form 4 for any further ownership details or related disclosures.